Utilization of Software Application FeaturesPAMLTIPSNCT00657462
Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts
A study testing Reminders in people with Utilization of Software Application Features, run by Brigham and Women's Hospital at 2 sites in United States.
Trial summary
This project will study whether reminder prompts increase PAML Builder application feature utilization. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Utilization of Software Application Features
- What is being tested?
- Reminders
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 14,122 participants
- Where
- 2 sitesUnited States
- Study dates
- Apr 2008to Jul 2008
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- users of the PAML Builder application (physicians, nurses, pharmacists)
Who cannot join
- none
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Massachusetts General Hospital
Boston, Massachusetts, 02114
Brigham and Women's Hospital
Boston, Massachusetts, 02115
About this study
Official title: Effect of Reminder Prompts on Utilization of the PAML Builder Application Features
This project will study whether reminder prompts increase PAML Builder application feature utilization.
Read the detailed description
This project will study whether reminder prompts increase Pre-Admission Medication List (PAML) Builder application feature utilization. PAML Builder is an application designed and maintained by Partners Information Systems that assists clinicians in medication reconciliation - a process important for patient safety and quality of care. We have determined that several potentially helpful features of the application are not being utilized as frequently as had been expected. These features include:
- copying the pre-admission medication list (PAML) to the clipboard
- viewing the detailed audit trail of all changes made to the PAML
- sorting the list of medications obtained from other electronic sources by therapeutic class.
Reminder prompts (sometimes referred to as "Tip of the Day") have been employed to increase user awareness of underutilized application features. However, anecdotally some users find them unhelpful and potentially irritating. It is therefore important to determine whether reminder prompts accomplish the stated task of increasing application feature utilization. This project will compare PAML Builder application feature utilization before and after a pilot rollout of reminder prompts to determine whether they should be implemented permanently.
- Being tested
- Reminders
- Keywords
- Medical Informatics Applications, Software, Utilization
- Medical subject headings
- Patient Acceptance of Health Care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RemindersOther
Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application
| Study group | Role | What they receive |
|---|---|---|
| A | Experimental | Receives the intervention (reminders displayed at the startup of the application) for both periods (period 1 and period 2) of the study. Receives: Other: Reminders |
| B | Active comparator | Receives the intervention (reminders displayed at the application startup) only during the second period (period 2) of the study. Receives: Other: Reminders |
What is being measured
The primary outcome is the main question the study is designed to answer.
Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms).
Measured: The entire study period
Secondary outcomes (3)
Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms).
Measured: The entire study period
Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminder.
Measured: The entire study period
Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminders.
Measured: The entire study period.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2008 (estimated)
- Study startApr 2008
- Primary completionJul 2008
- Study completionJul 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Utilization of Software Application FeaturesStudies of the same condition, open and under way.
- More trials run by Brigham and Women's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 14,122 participants (actual)
Sponsor and investigators
- Lead sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Massachusetts General Hospital
- Responsible party
- Principal investigator, Alexander Turchin, Brigham and Women's Hospital
- Investigators
- Alexander Turchin, MD, MS, Principal investigator, Partners HealthCareCarol Broverman, PhD, Principal investigator, Partners HealthCare
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00657462
- Sponsor's protocol ID
- PAMLTIPS
- Acronym
- PAMLTIPS
- Status last verified
- Jan 2017
- First submitted
- 9 Apr 2008
- Last updated
- 31 Jan 2017
- Results posted
- No
- Data monitoring committee
- No
Publications
Poon EG, Blumenfeld B, Hamann C, Turchin A, Graydon-Baker E, McCarthy PC, Poikonen J, Mar P, Schnipper JL, Hallisey RK, Smith S, McCormack C, Paterno M, Coley CM, Karson A, Chueh HC, Van Putten C, Millar SG, Clapp M, Bhan I, Meyer GS, Gandhi TK, Broverman CA. Design and implementation of an application and associated services to support interdisciplinary medication reconciliation efforts at an integrated healthcare delivery network. J Am Med Inform Assoc. 2006 Nov-Dec;13(6):581-92. doi: 10.1197/jamia.M2142.
PubMed 17114640Turchin A, Gandhi TK, Coley CM, Shubina M, Broverman C. The use of electronic medication reconciliation to establish the predictors of validity of computerized medication records. Stud Health Technol Inform. 2007;129(Pt 2):1022-6.
PubMed 17911870
Study at a glance
From the registry record, last updated by the sponsor on 31 Jan 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Reminder Prompts on Utilization of the PAML Builder Application Features
- ClinicalTrials.gov ID
- NCT00657462
- Acronym / sponsor ID
- PAMLTIPS / PAMLTIPS
- Keywords
- Medical Informatics Applications, Software, Utilization
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 14,122 participants (actual)
- Lead sponsor
- Brigham and Women's HospitalUniversity, hospital or other
- Collaborators
- Massachusetts General Hospital
- Study start
- Apr 2008
- Primary completion
- Jul 2008 (actual)
- Study completion
- Jul 2008 (actual)
- First posted
- 14 Apr 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project will study whether reminder prompts increase PAML Builder application feature utilization.
Detailed description
This project will study whether reminder prompts increase Pre-Admission Medication List (PAML) Builder application feature utilization. PAML Builder is an application designed and maintained by Partners Information Systems that assists clinicians in medication reconciliation - a process important for patient safety and quality of care. We have determined that several potentially helpful features of the application are not being utilized as frequently as had been expected. These features include:
- copying the pre-admission medication list (PAML) to the clipboard
- viewing the detailed audit trail of all changes made to the PAML
- sorting the list of medications obtained from other electronic sources by therapeutic class.
Reminder prompts (sometimes referred to as "Tip of the Day") have been employed to increase user awareness of underutilized application features. However, anecdotally some users find them unhelpful and potentially irritating. It is therefore important to determine whether reminder prompts accomplish the stated task of increasing application feature utilization. This project will compare PAML Builder application feature utilization before and after a pilot rollout of reminder prompts to determine whether they should be implemented permanently.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| A | Experimental | Other: RemindersReceives the intervention (reminders displayed at the startup of the application) for both periods (period 1 and period 2) of the study. |
| B | Active comparator | Other: RemindersReceives the intervention (reminders displayed at the application startup) only during the second period (period 2) of the study. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- users of the PAML Builder application (physicians, nurses, pharmacists)
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RemindersUsers of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application | Other | A, B |
Primary outcome
Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms).
Time frame: The entire study period
3 secondary outcomes
Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms).
Time frame: The entire study period
Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminder.
Time frame: The entire study period
Difference in the change between frequencies of utilization of the individual features promoted by the reminders per PAML built between the two arms from period 1 to period 2 by the users who were displayed the corresponding reminders.
Time frame: The entire study period.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jan 2017.
- Background: PubMed 17114640Poon EG, Blumenfeld B, Hamann C, Turchin A, Graydon-Baker E, McCarthy PC, Poikonen J, Mar P, Schnipper JL, Hallisey RK, Smith S, McCormack C, Paterno M, Coley CM, Karson A, Chueh HC, Van Putten C, Millar SG, Clapp M, Bhan I, Meyer GS, Gandhi TK, Broverman CA. Design and implementation of an application and associated services to support interdisciplinary medication reconciliation efforts at an integrated healthcare delivery network. J Am Med Inform Assoc. 2006 Nov-Dec;13(6):581-92. doi: 10.1197/jamia.M2142.
- Background: PubMed 17911870Turchin A, Gandhi TK, Coley CM, Shubina M, Broverman C. The use of electronic medication reconciliation to establish the predictors of validity of computerized medication records. Stud Health Technol Inform. 2007;129(Pt 2):1022-6.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alexander Turchin, MD, MS principal investigator
Partners HealthCare
Carol Broverman, PhD principal investigator
Partners HealthCare
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Reminders in people with Utilization of Software Application Features, run by Brigham and Women's Hospital at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Difference in the change between combined frequency of utilization of all features promoted by the reminders per PAML built between the two arms from period 1 (intervention in one arm only) to period 2 (intervention in both arms). (time frame: The entire study period). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00657462, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2017.